X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (54) 54
index medicus (39) 39
oncology (38) 38
female (33) 33
cancer (32) 32
risk (29) 29
genetic predisposition to disease (26) 26
middle aged (26) 26
adult (24) 24
mutation (24) 24
breast cancer (22) 22
genetic aspects (22) 22
male (22) 22
brca1 (21) 21
breast neoplasms - genetics (20) 20
risk factors (20) 20
aged (19) 19
genes, brca1 (17) 17
prostate cancer (17) 17
research (17) 17
gene mutations (15) 15
genetics & heredity (15) 15
women (15) 15
brca2 (14) 14
genetics (13) 13
medical and health sciences (13) 13
medicin och hälsovetenskap (13) 13
ovarian cancer (13) 13
ovarian neoplasms - genetics (13) 13
prostatic neoplasms - genetics (13) 13
carriers (12) 12
epidemiology (12) 12
genes, brca2 (12) 12
norway (12) 12
ovarian-cancer (12) 12
prostate (12) 12
genetic testing (11) 11
genome-wide association study (11) 11
health aspects (11) 11
survival (11) 11
diagnosis (10) 10
medical genetics (10) 10
science (10) 10
brca1 protein - genetics (9) 9
breast-cancer (9) 9
multidisciplinary sciences (9) 9
polymorphism, single nucleotide (9) 9
article (8) 8
clinical medicine (8) 8
genomes (8) 8
klinisk medicin (8) 8
loci (8) 8
skin and connective tissue diseases (8) 8
brca2 protein - genetics (7) 7
cancer and oncology (7) 7
cancer och onkologi (7) 7
case-control studies (7) 7
neoplasms. tumors. oncology. including cancer and carcinogens (7) 7
norway - epidemiology (7) 7
breast (6) 6
breast neoplasms - diagnosis (6) 6
breast neoplasms - epidemiology (6) 6
consortia (6) 6
disease (6) 6
dna mutational analysis (6) 6
endocrine system diseases (6) 6
family-history (6) 6
genes (6) 6
genome-wide association (6) 6
germ-line mutation (6) 6
health risks (6) 6
heterozygote (6) 6
medicine (6) 6
metaanalysis (6) 6
nonpolyposis colorectal-cancer (6) 6
pedigree (6) 6
prevention (6) 6
public, environmental & occupational health (6) 6
susceptibility (6) 6
tumors (6) 6
variants (6) 6
age (5) 5
basic medicine (5) 5
brca mutations (5) 5
breast neoplasms - pathology (5) 5
care and treatment (5) 5
colorectal cancer (5) 5
colorectal neoplasms, hereditary nonpolyposis - genetics (5) 5
expression (5) 5
genetic screening (5) 5
genotype (5) 5
germline mutations (5) 5
health risk assessment (5) 5
incidence (5) 5
journal article (5) 5
mammography (5) 5
medicine & public health (5) 5
medicinsk genetik (5) 5
medicinska och farmaceutiska grundvetenskaper (5) 5
oncology, experimental (5) 5
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


PLoS ONE, ISSN 1932-6203, 08/2008, Volume 3, Issue 8, p. e3062
Background: Chemoresistance is the main obstacle to cure in most malignant diseases. Anthracyclines are among the main drugs used for breast cancer therapy and... 
BIOLOGY | Promoter Regions, Genetic | Humans | Protein-Serine-Threonine Kinases - genetics | Drug Resistance, Neoplasm | Breast Neoplasms - drug therapy | Tumor Suppressor Protein p53 - genetics | Breast Neoplasms - enzymology | DNA Methylation | Breast Neoplasms - genetics | Antibiotics, Antineoplastic - therapeutic use | Breast Neoplasms - pathology | DNA Mutational Analysis | Checkpoint Kinase 2 | Epirubicin - therapeutic use | RNA, Neoplasm - genetics | Female | DNA, Neoplasm - genetics | Mutation | Neoplasm Staging | Anthracyclines | Care and treatment | Oncology, Experimental | Genes | Breast cancer | Research | Drug resistance | Gene expression | Ionizing radiation | Gene mutations | Analysis | Genetic research | Genetic aspects | Tumor proteins | Health aspects | Cancer | Drugs | Therapy | Senescence | p53 Protein | DNA damage | Chemoresistance | Oncology | Metastasis | Kinases | Cancer therapies | Proteins | Cascades | Fibroblasts | Epirubicin | Dimerization | Drug dosages | Deoxyribonucleic acid--DNA | Medical research | Damage assessment | CHK2 protein | Patients | Medicine | Studies | Chemotherapy | Damage detection | Anthracycline | Response rates | Breast | Molecular biology | Tumors | Apoptosis | VDP | Oncology: 762 | Klinisk medisinske fag: 750 | Onkologi: 762 | Medisinske Fag: 700 | Clinical medical disciplines: 750 | Medical disciplines: 700 | Deoxyribonucleic acid | DNA
Journal Article
HEREDITARY CANCER IN CLINICAL PRACTICE, ISSN 1731-2302, 05/2019, Volume 17, Issue 1, pp. 14 - 8
Background: Pathogenic variants in BRCA1 and BRCA2 cause hereditary breast and ovarian cancer. Screening of these genes has become easily accessible in... 
BREAST-CANCER | Splicing | ONCOLOGY | RT-PCR | POLYPYRIMIDINE TRACT | Variant classification | mRNA | BRCA1 | OVARIAN-CANCER | BRCA2 | Variant of unknown significance | Messenger RNA | Analysis | Genetic research | Genetic aspects | Genetic transcription | Research | Diagnosis | Ovarian cancer | Cancer | Consortia | BRCA2 protein | BRCA1 protein | Laboratories | Copy number | Genes | Classification | Reverse transcription | Breast cancer | Mutation
Journal Article
Journal Article
Human Mutation, ISSN 1059-7794, 05/2011, Volume 32, Issue 5, pp. 568 - 571
A method for SImplified rapid Segregation Analysis (SISA) to assess penetrance and expression of genetic variants in pedigrees of any complexity is presented.... 
expression | segregation analysis | VUS | inherited | penetrance | Segregation analysis | Penetrance | Inherited | Expression | GENETICS & HEREDITY | MUTATIONS | CANCER | CARRIERS | BREAST | Genetic Variation | Models, Theoretical | Computational Biology - methods | Genetic Predisposition to Disease | Humans | Family | Methods
Journal Article
Journal Article
Hereditary Cancer in Clinical Practice, ISSN 1731-2302, 01/2018, Volume 16, Issue 1, pp. 3 - 15
Background: Founder mutations in the two breast cancer genes, BRCA1 and BRCA2, have been described in many populations, among these are Ashkenazi-Jewish,... 
Founder mutations | BRCA1 | Genetic testing | BRCA2 | POPULATION | RISKS | BRCA2 MUTATIONS | SEQUENCE VARIANTS | OVARIAN-CANCER | FAMILY-HISTORY | CARRIERS | BREAST | ONCOLOGY | EPIDEMIOLOGY | Prevention | Gene mutations | Medical care | Genetic aspects | Genetic screening | Cancer | Quality management | Usage | Research | BRCA mutations
Journal Article
by Schumacher, Fredrick R and Al Olama, Ali Amin and Berndt, Sonja I and Benlloch, Sara and Ahmed, Mahbubl and Saunders, Edward J and Dadaev, Tokhir and Leongamornlert, Daniel and Anokian, Ezequiel and Cieza-Borrella, Clara and Goh, Chee and Brook, Mark N and Sheng, Xin and Fachal, Laura and Dennis, Joe and Tyrer, Jonathan and Muir, Kenneth and Lophatananon, Artitaya and Stevens, Victoria L and Gapstur, Susan M and Carter, Brian D and Tangen, Catherine M and Goodman, Phyllis J and Thompson, Ian M and Batra, Jyotsna and Chambers, Suzanne and Moya, Leire and Clements, Judith and Horvath, Lisa and Tilley, Wayne and Risbridger, Gail P and Gronberg, Henrik and Aly, Markus and Nordström, Tobias and Pharoah, Paul and Pashayan, Nora and Schleutker, Johanna and Tammela, Teuvo L. J and Sipeky, Csilla and Auvinen, Anssi and Albanes, Demetrius and Weinstein, Stephanie and Wolk, Alicja and Håkansson, Niclas and West, Catharine M. L and Dunning, Alison M and Burnet, Neil and Mucci, Lorelei A and Giovannucci, Edward and Andriole, Gerald L and Cussenot, Olivier and Cancel-Tassin, Géraldine and Koutros, Stella and Beane Freeman, Laura E and Sorensen, Karina Dalsgaard and Orntoft, Torben Falck and Borre, Michael and Maehle, Lovise and Grindedal, Eli Marie and Neal, David E and Donovan, Jenny L and Hamdy, Freddie C and Martin, Richard M and Travis, Ruth C and Key, Tim J and Hamilton, Robert J and Fleshner, Neil E and Finelli, Antonio and Ingles, Sue Ann and Stern, Mariana C and Rosenstein, Barry S and Kerns, Sarah L and Ostrer, Harry and Lu, Yong-Jie and Zhang, Hong-Wei and Feng, Ninghan and Mao, Xueying and Guo, Xin and Wang, Guomin and Sun, Zan and Giles, Graham G and Southey, Melissa C and MacInnis, Robert J and Fitzgerald, Liesel M and Kibel, Adam S and Drake, Bettina F and Vega, Ana and Gómez-Caamaño, Antonio and Szulkin, Robert and Eklund, Martin and Kogevinas, Manolis and Llorca, Javier and Castaño-Vinyals, Gemma and Penney, Kathryn L and Stampfer, Meir and Park, Jong Y and Sellers, Thomas A and Lin, Hui-Yi and Stanford, Janet L and Cybulski, Cezary and ... and Profile Study and Canary PASS Investigators and Canc Prostate Sweden CAPS and IMPACT Study and Prostate Canc Genome-wide As and APCB and Breast Prostate Canc Cohort Consor and PRACTICAL Prostate Canc As and Genetic Assoc Mech Oncology GAME and Breast and Prostate Cancer Cohort Consortium (BPC3) and Prostate Cancer Genome-wide Association Study of Uncommon Susceptibility Loci (PEGASUS) and Australian Prostate Cancer BioResource (APCB) and Genetic Associations and Mechanisms in Oncology (GAME-ON)/Elucidating Loci Involved in Prostate Cancer Susceptibility (ELLIPSE) Consortium and Cancer of the Prostate in Sweden (CAPS) and PRACTICAL (Prostate Cancer Association Group to Investigate Cancer-Associated Alterations in the Genome) Consortium and The PRACTICAL (Prostate Cancer Association Group to Investigate Cancer-Associated Alterations in the Genome) Consortium and The IMPACT Study and The Profile Study and The Genetic Associations and Mechanisms in Oncology (GAME-ON)/Elucidating Loci Involved in Prostate Cancer Susceptibility (ELLIPSE) Consortium and Medicinska fakulteten and Medicinska och farmaceutiska vetenskapsområdet and Ortopedi and Uppsala universitet and Institutionen för kirurgiska vetenskaper
Nature Genetics, ISSN 1061-4036, 07/2018, Volume 50, Issue 7, pp. 928 - 936
Journal Article